ENVBEnveric Biosciences, Inc.

Nasdaq enveric.com


$ 0.90 $ -0.01 (-0.56 %)    

Friday, 26-Apr-2024 14:02:36 EDT
QQQ $ 431.01 $ 6.55 (1.54 %)
DIA $ 382.27 $ 1.39 (0.36 %)
SPY $ 508.26 $ 4.77 (0.95 %)
TLT $ 88.26 $ 0.46 (0.52 %)
GLD $ 216.60 $ 0.70 (0.32 %)
$ 0.895
$ 0.90
$ 0.90 x 100
$ 0.00 x 0
$ 0.90 - $ 0.90
$ 0.65 - $ 6.98
58,269
na
1.93M
$ 1.50
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-26-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-11-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 03-31-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-12-2022 06-30-2022 10-Q
8 05-13-2022 03-31-2022 10-Q
9 03-31-2022 12-31-2021 10-K
10 11-13-2021 09-30-2021 10-Q
11 08-13-2021 06-30-2021 10-Q
12 05-17-2021 03-31-2021 10-Q
13 04-01-2021 12-31-2020 10-K
14 11-16-2020 09-30-2020 10-Q
15 08-14-2020 06-30-2020 10-Q
16 05-15-2020 03-31-2020 10-Q
17 03-25-2020 12-31-2019 10-K
18 11-08-2019 09-30-2019 10-Q
19 08-14-2019 06-30-2019 10-Q
20 05-14-2019 03-31-2019 10-Q
21 03-26-2019 12-31-2018 10-K
22 11-14-2018 09-30-2018 10-Q
23 08-14-2018 06-30-2018 10-Q
24 05-15-2018 03-31-2018 10-Q
25 04-02-2018 12-31-2017 10-K
26 11-13-2017 09-30-2017 10-Q
27 08-14-2017 06-30-2017 10-Q
28 05-12-2017 03-31-2017 10-Q
29 03-31-2017 12-31-2016 10-K
30 11-14-2016 09-30-2016 10-Q
31 08-12-2016 06-30-2016 10-Q
32 05-16-2016 03-31-2016 10-Q
33 11-23-2015 09-30-2015 10-Q
34 08-14-2015 06-30-2015 10-Q
35 05-14-2015 03-31-2015 10-Q
36 03-31-2015 12-31-2014 10-K
37 11-13-2014 09-30-2014 10-Q
38 08-11-2014 06-30-2014 10-Q
39 05-07-2014 03-31-2014 10-Q
40 03-28-2014 12-31-2013 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 why-ulta-beauty-shares-are-trading-lower-by-around-14-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) fell sharply during Wednesday’s session amid the company's presentation at the ...

 enveric-biosciences-canada-granted-us-patent-11931338-nitrilated-psilocybin-derivatives-and-methods-of-using

https://ppubs.uspto.gov/dirsearch-public/print/downloadPdf/11931338

 why-peraso-shares-are-trading-lower-by-over-23-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected four...

 nasdaq-down-100-points-us-housing-starts-surge-in-february

U.S. stocks traded mixed this morning, with the Nasdaq Composite falling around 100 points on Tuesday. Following the market op...

 why-is-anxietyaddiction-focused-enveric-biosciences-stock-trading-higher-tuesday

Enveric Biosciences announces significant progress with non-binding term sheets signed with a biotech firm for cannabinoid-COX-...

 the-pharmaceutical-application-term-sheet-provides-enveric-biosciences-could-be-eligible-to-receive-future-development-and-sales-milestone-payments-that-in-total-could-add-up-to-approximately-61m

Royalty rates could range from 2.5% up to 10% on future sales, depending on meeting certain sales criteria.

Core News & Articles

https://www.marijuanamoment.net/indiana-lawmakers-send-psilocybin-research-funding-bill-to-governor/   The Indiana legislatur...

 enveric-biosciences-canada-awarded-us-patent-11918594--multi-substituent-psilocybin-derivatives-and-methods-of-using

https://ppubs.uspto.gov/dirsearch-public/print/downloadPdf/11918594

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION